The aim of this study was to characterize and cross-validate TGF-β-mediated EMT in CMT64 mouse lung adenocarcinoma cell line and its tumorigenesis in a syngeneic transplantation model. This evidence concerns the gene TGFB1 and lung adenocarcinoma.